Factor Therapeutics (ASX:FTT) - Non-Executive Director, David Brookes
Non
Source: Factor Therapeutics
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Factor Therapeutics (FTT) has completed its name change to Dominion Minerals, shifting its focus to copper and gold exploration
  • Further, Dominion finished acquiring PowerLime, agreeing to issue 18.75 million shares to PowerLime’s shareholders at 4 cents per share
  • As part of the company’s application to relist on the ASX, it’s looking to raise $4 million through the issue of 100 million shares
  • The company has set aside $800,000 of the offer proceeds to allocate to existing shareholders, which it says have been significantly exceeded
  • Factor Therapeutics last traded at 0.5 cents

Factor Therapeutics (FTT) has officially completed its name change to Dominion Minerals.

The name change marks Factor’s transition from a biotechnology company to a resources company.

Dominion Minerals is now a copper and gold exploration and development company, which is focused on parts of China and Panama.

Further to this, Dominion Minerals has completed its acquisition of PowerLime.

Having satisfied all necessary conditions, Dominion has purchased all issued capital of PowerLime.

As a result of this, Dominion will issue 18.75 million shares to PowerLime’s shareholders at 4 cents per share, representing an acquisition value of A$750,000.

Over 6 million options will also go to PowerLime shareholders, along with 4.68 million options to the management team. The options will be exercisable at 12 cents each and have a four-year exercise date.

As part of the company’s application to relist on the ASX, it’s looking to raise $4 million through the issue of 100 million shares. This offer is set to close on October 1.

The company set aside $800,000 of the offer proceeds for allocation to existing shareholders, which it says have been significantly exceeded.  

Factor Therapeutics last traded at 0.5 cents. 

FTT by the numbers
More From The Market Herald
Ballymore Resources (ASX:BMR) - Non Executive Chairman, Nick Jorss

" Ballymore Resources (ASX:BMR) intersects significant assays at Seventy Mile Mount

Ballymore Resources (ASX:BMR) has intersected significant assays in its initial drilling program at the Seventy Mile…

" Ballymore Resources (ASX:BMR) begins stage one drilling at Ruddygore

Ballymore Resources (ASX:BMR) has begun stage one drilling at the Ruddygore Prospect in North Queensland.

" Ballymore Resources (ASX:BMR) confirms displacement of Duffer lode at Dittmer mine, QLD

Ballymore Resources (ASX:BMR) has confirmed through diamond drilling that the historic Duffer lode at its Dittmer…

" Bannerman Energy (ASX:BMN) completes $40.7m institutional placement

Bannerman Energy (ASX:BMN) has raised $40.7 million via institutional placement, with the funds to be used…